{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:03:06Z","timestamp":1777496586650,"version":"3.51.4"},"reference-count":19,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b16-00946","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T18:17:58Z","timestamp":1504203478000},"page":"1352-1360","source":"Crossref","is-referenced-by-count":7,"title":["Chronic Rapamycin Treatment Improved Metabolic Phenotype but Inhibited Adipose Tissue Browning in High-Fat Diet-Fed C57BL\/6J Mice"],"prefix":"10.1248","volume":"40","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[{"name":"Pharmacy Department, The First People\u2019s Hospital of Foshan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"He","sequence":"additional","affiliation":[{"name":"Medical School of China Three Gorges University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianhui","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Medicine, College of Medicine, Jishou University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell<\/i>, 124<\/b>, 471\u2013484 (2006).","DOI":"10.1016\/j.cell.2006.01.016"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Scott KL, Kabbarah O, Liang M-C, Ivanova E, Anagnostou V, Wu J, Dhakal S, Wu M, Chen S, Feinberg T, Huang J, Saci A, Widlund HR, Fisher DE, Xiao Y, Rimm DL, Protopopov A, Wong K-K, Chin L. GOLPH3 modulates mTOR signaling and rapamycin sensitivity in cancer. Nature<\/i>, 459<\/b>, 1085\u20131090 (2009).","DOI":"10.1038\/nature08109"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ray PD, Maclellan RA, He J, Liu Z, Wu J. Downregulation of RelA (p65) by rapamycin inhibits murine adipocyte differentiation and reduces fat mass of C57BL\/6J mice despite high fat diet. ISRN. Obes.<\/i>, 2014<\/b>, 540582 (2014).","DOI":"10.1155\/2014\/540582"},{"key":"4","unstructured":"4) Wang Y, He Z, Li X, Chen W, Lu J, Chen X, Cao L. Chronic rapamycin treatment exacerbates metabolism and does not down-regulate mTORC2\/Akt signaling in diabetic mice induced by high-fat diet and streptozotocin. Pharmazie<\/i>, 70<\/b>, 604\u2013609 (2015)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Houde VP, Br\u00fbl\u00e9 S, Festuccia WT, Blanchard PG, Bellmann K, Deshaies Y, Marette A. Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes<\/i>, 59<\/b>, 1338\u20131348 (2010).","DOI":"10.2337\/db09-1324"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Chakrabarti P, English T, Shi J, Smas CM, Kandror KV. Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage. Diabetes<\/i>, 59<\/b>, 775\u2013781 (2010).","DOI":"10.2337\/db09-1602"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Fu T, Seok S, Choi S, Huang Z, Suino-Powell K, Xu HE, Kemper B, Kemper JK. MicroRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function. Mol. Cell. Biol.<\/i>, 34<\/b>, 4130\u20134142 (2014).","DOI":"10.1128\/MCB.00596-14"},{"key":"8","unstructured":"8) Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev.<\/i>, 84<\/b>, 277\u2013359 (2004)."},{"key":"9","unstructured":"9) Sidossis L, Kajimura S. Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis. J. Clin. Invest.<\/i>, 125<\/b>, 478\u2013486 (2015)."},{"key":"10","unstructured":"10) Cohen P, Spiegelman BM. Brown and beige fat: molecular parts of a thermogenic machine. Diabetes<\/i>, 64<\/b>, 2346\u20132351 (2015)."},{"key":"11","unstructured":"11) Khamzina L, Veilleux A, Bergeron S, Marette A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology<\/i>, 146<\/b>, 1473\u20131481 (2005)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Rivas DA, Yaspelkis BB 3rd, Hawley JA, Lessard SJ. Lipid-induced mTOR activation in rat skeletal muscle reversed by exercise and 5\u2032-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside. J. Endocrinol.<\/i>, 202<\/b>, 441\u2013451 (2009).","DOI":"10.1677\/JOE-09-0202"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Bell E, Cao X, Moibi JA, Greene SR, Young R, Trucco M, Gao Z, Matschinsky FM, Deng S, Markman JF, Naji A, Wolf BA. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes<\/i>, 52<\/b>, 2731\u20132739 (2003).","DOI":"10.2337\/diabetes.52.11.2731"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fraenkel M, Ketzinel-Gilad M, Ariav Y, Pappo O, Karaca M, Castel J, Berthault MF, Magnan C, Cerasi E, Kaiser N, Leibowitz G. mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes<\/i>, 57<\/b>, 945\u2013957 (2008).","DOI":"10.2337\/db07-0922"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Baeder WL, Sredy J, Sehgal SN, Chang JY, Adams LM. Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice. Clin. Exp. Immunol.<\/i>, 89<\/b>, 174\u2013178 (1992).","DOI":"10.1111\/j.1365-2249.1992.tb06928.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Makki K, Taront S, Molendi-Coste O, Bouchaert E, Neve B, Eury E, Lobbens S, Labalette M, Duez H, Staels B, Dombrowicz D, Froguel P, Wolowczuk I. Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice. PLOS ONE<\/i>, 9<\/b>, e92684 (2014).","DOI":"10.1371\/journal.pone.0092684"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Hebert M, Licursi M, Jensen B, Baker A, Milway S, Malsbury C, Grant VL, Adamec R, Hirasawa M, Blundell J. Single rapamycin administration induces prolonged downward shift in defended body weight in rats. PLOS ONE<\/i>, 9<\/b>, e93691 (2014).","DOI":"10.1371\/journal.pone.0093691"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Liu D, Bordicchia M, Zhang C, Fang H, Wei W, Li JL, Guilherme A, Guntur K, Czech MP, Collins S. Activation of mTORC1 is essential for \u03b2-adrenergic stimulation of adipose browning. J. Clin. Invest.<\/i>, 126<\/b>, 1704\u20131716 (2016).","DOI":"10.1172\/JCI83532"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Xiang X, Lan H, Tang H, Yuan F, Xu Y, Zhao J, Li Y, Zhang W. Tuberous sclerosis complex 1-mechanistic target of rapamycin complex 1 signaling determines brown-to-white adipocyte phenotypic switch. Diabetes<\/i>, 64<\/b>, 519\u2013528 (2015).","DOI":"10.2337\/db14-0427"}],"container-title":["Biological & Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/9\/40_b16-00946\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T20:50:57Z","timestamp":1570049457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/9\/40_b16-00946\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00946","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}